Prevention and treatment of autoimmune diseases with plant virus nanoparticles
Author(s) -
Roberta Zampieri,
Annalisa Brozzetti,
Eva Pericolini,
Elena Bartoloni,
Elena Gabrielli,
Elena Roselletti,
George P Lomonosoff,
Yulia Meshcheriakova,
Luca Santi,
Francesca Imperatori,
Matilde Merlin,
Elisa Tinazzi,
Francesco Dotta,
Laura Nigi,
Guido Sebastiani,
Mario Pezzotti,
Alberto Falorni,
Linda Avesani
Publication year - 2020
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aaz0295
Subject(s) - virus , virology , virus diseases , medicine , nanoparticle , biology , immunology , nanotechnology , materials science
Plant viruses are natural, self-assembling nanostructures with versatile and genetically programmable shells, making them useful in diverse applications ranging from the development of new materials to diagnostics and therapeutics. Here, we describe the design and synthesis of plant virus nanoparticles displaying peptides associated with two different autoimmune diseases. Using animal models, we show that the recombinant nanoparticles can prevent autoimmune diabetes and ameliorate rheumatoid arthritis. In both cases, this effect is based on a strictly peptide-related mechanism in which the virus nanoparticle acts both as a peptide scaffold and as an adjuvant, showing an overlapping mechanism of action. This successful preclinical testing could pave the way for the development of plant viruses for the clinical treatment of human autoimmune diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom